BioScience Health Innovations, Inc. (BHIC)
OTCMKTS · Delayed Price · Currency is USD
4.000
0.00 (0.00%)
At close: Aug 10, 2026
BHIC Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.71 | 0.66 | 0.66 | 0.02 | 0.01 | 0 |
Cash & Short-Term Investments | 0.71 | 0.66 | 0.66 | 0.02 | 0.01 | 0 |
Cash Growth | -45.18% | -0.09% | 3343.79% | 66.29% | 11469.00% | - |
Accounts Receivable | 0.4 | 0.4 | 0.1 | 0.04 | 0.01 | - |
Other Receivables | 0.03 | 0.14 | 0.02 | - | - | - |
Receivables | 0.43 | 0.54 | 0.12 | 0.04 | 0.01 | - |
Inventory | 0.8 | 0.34 | 0.06 | 0.04 | 0.01 | - |
Prepaid Expenses | 0.04 | 0.02 | 0 | - | - | - |
Total Current Assets | 1.99 | 1.56 | 0.85 | 0.09 | 0.03 | 0 |
Property, Plant & Equipment | 0.03 | 0.06 | - | - | - | - |
Other Intangible Assets | 0.11 | 0.08 | 0.03 | - | - | - |
Other Long-Term Assets | 0 | 0 | - | - | - | - |
Total Assets | 2.14 | 1.71 | 0.87 | 0.09 | 0.03 | 0 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.01 | 0.01 | 0.01 | 0.01 | 0 | - |
Accrued Expenses | 0.03 | 0.01 | 0.01 | 0 | - | - |
Short-Term Debt | 0.26 | - | - | 0.09 | 0.05 | 0 |
Current Income Taxes Payable | - | 0.08 | - | - | - | - |
Current Unearned Revenue | 0 | 0.14 | 0.02 | 0 | - | - |
Total Current Liabilities | 0.3 | 0.23 | 0.04 | 0.1 | 0.05 | 0 |
Total Liabilities | 0.3 | 0.23 | 0.04 | 0.1 | 0.05 | 0 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0.01 | 0.01 |
Additional Paid-In Capital | 1.95 | 1.18 | 1.17 | 0.42 | 0.15 | - |
Retained Earnings | -0.11 | 0.3 | -0.34 | -0.43 | -0.18 | -0.01 |
Total Common Equity | 1.83 | 1.48 | 0.84 | -0.01 | -0.02 | -0 |
Shareholders' Equity | 1.83 | 1.48 | 0.84 | -0.01 | -0.02 | -0 |
Total Liabilities & Equity | 2.14 | 1.71 | 0.87 | 0.09 | 0.03 | 0 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.26 | - | - | 0.09 | 0.05 | 0 |
Net Cash (Debt) | 0.45 | 0.66 | 0.66 | -0.07 | -0.03 | -0 |
Net Cash Growth | -63.89% | -0.09% | - | - | - | - |
Net Cash Per Share | 0.04 | 0.06 | 0.06 | -0.01 | -0.02 | -0.00 |
Filing Date Shares Outstanding | 11.75 | 11.37 | 10.98 | 10.4 | 1.37 | 0.85 |
Total Common Shares Outstanding | 11.75 | 10.98 | 10.98 | 10.4 | 2.42 | 0.85 |
Working Capital | 1.69 | 1.33 | 0.81 | -0.01 | -0.02 | -0 |
Book Value Per Share | 0.16 | 0.13 | 0.08 | -0.00 | -0.01 | -0.00 |
Tangible Book Value | 1.73 | 1.39 | 0.81 | -0.01 | -0.02 | -0 |
Tangible Book Value Per Share | 0.15 | 0.13 | 0.07 | -0.00 | -0.01 | -0.00 |